G Suay - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

G Suay

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Revista De Neurologia|March 26, 2019

[Checkpoint inhibitors neurological side effects]G Suay, L Bataller

ESMO Real World Data and Digital Oncology|July 1, 2026

First-line osimertinib in advanced <i>EGFR</i>-mutated NSCLC: real-world outcomes, clinicogenomic correlates, and oligoprogression management in a multicenter Spanish cohortG Suay, S Cases-Esteban, P Capdevila, et al.

ESMO Open|April 3, 2025

LUDICAS: sexual dysfunction in patients with lung cancer, a multicenter cross-sectional studyA V Ospina-Serrano, A Collazo-Lorduy, E Azkona-Uribelarrea, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Revista De Neurologia|March 26, 2019

[Checkpoint inhibitors neurological side effects]G Suay, L Bataller

ESMO Real World Data and Digital Oncology|July 1, 2026

First-line osimertinib in advanced <i>EGFR</i>-mutated NSCLC: real-world outcomes, clinicogenomic correlates, and oligoprogression management in a multicenter Spanish cohortG Suay, S Cases-Esteban, P Capdevila, et al.

ESMO Open|April 3, 2025

LUDICAS: sexual dysfunction in patients with lung cancer, a multicenter cross-sectional studyA V Ospina-Serrano, A Collazo-Lorduy, E Azkona-Uribelarrea, et al.

Pageof 1